Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies

Manankar Koley; Jingjing Han; Vadim A. Soloshonok; Subhajit Mojumder; Ramin Javahershenas; Ata Makarem

doi:10.1039/d3md00511a

journal article Open Access Jan 01, 2024

Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies

Manankar Koley

Jingjing Han

Vadim A. Soloshonok

Subhajit Mojumder Ramin Javahershenas

Ata Makarem

RSC Medicinal Chemistry Vol. 15 No. 1 pp. 10-54 · Royal Society of Chemistry (RSC)

View at Publisher Save 10.1039/d3md00511a

Abstract

Recent advances in coumarin-based anticancer agents.

Topics

No keywords indexed for this article. Browse by subject →

References

241

[1]

World Health Organization , Cancer , https://www.who.int/news-room/fact-sheets/detail/cancer

[2]

Siegel Ca-Cancer J. Clin. (2022) 10.3322/caac.21708

[3]

Pinto Curr. Top. Med. Chem. (2017)

[4]

Nayeli Nat. Prod. Res. (2020) 10.1080/14786419.2018.1553172

[5]

Mu Chem. Biodiversity (2019) 10.1002/cbdv.201800559

[6]

Hu Eur. J. Med. Chem. (2018) 10.1016/j.ejmech.2017.11.100

[7]

Bhagat ACS Omega (2019) 10.1021/acsomega.8b02481

[8]

Singh ACS Omega (2019) 10.1021/acsomega.9b01109

[9]

Chougala Eur. J. Med. Chem. (2018) 10.1016/j.ejmech.2017.10.072

[10]

Hassan Eur. J. Med. Chem. (2016) 10.1016/j.ejmech.2016.07.056

[11]

Al-Majedy Syst. Rev. Pharm. (2016) 10.5530/srp.2017.1.6

[12]

Al-Majedy Molecules (2016) 10.3390/molecules21020135

[13]

Nagamallu Bioorg. Med. Chem. Lett. (2016) 10.1016/j.bmcl.2015.11.038

[14]

Kasperkiewicz Pharmacol. Rep. (2018) 10.1016/j.pharep.2018.06.002

[15]

Xie Bioorg. Med. Chem. (2016) 10.1016/j.bmc.2016.02.023

[16]

Jiang Eur. J. Med. Chem. (2018) 10.1016/j.ejmech.2018.01.055

[17]

Zhang Eur. J. Med. Chem. (2019) 10.1016/j.ejmech.2019.111587

[18]

Song Arch. Pharm. (2020) 10.1002/ardp.202000025

[19]

Huang Chin. J. Nat. Med. (2017)

[20]

Menezes Eur. J. Med. Chem. (2019) 10.1016/j.ejmech.2019.111637

[21]

Ma Food Chem. Toxicol. (2019) 10.1016/j.fct.2019.01.020

[22]

Kubrak Molecules (2019) 10.3390/molecules24091824

[23]

Singh Bioorg. Med. Chem. (2019) 10.1016/j.bmc.2019.06.033

[24]

Rawat Eur. J. Med. Chem. Rep. (2022)

[25]

R.Bhatia , A.Singh , B.Kumar and R. K.Rawal , in Key Heterocyclic Cores for Smart Anticancer Drug–Design Part II , Bentham Science Publishers , 2022 , pp. 35–78 10.2174/9789815040043122020005

[26]

Galeano J. Appl. Pharm. Sci. (2023)

[27]

Al-Warhi Bioorg. Chem. (2020) 10.1016/j.bioorg.2020.104163

[28]

Tu Angew. Chem., Int. Ed. (2016) 10.1002/anie.201601967

[29]

Liu Curr. Top. Med. Chem. (2019) 10.2174/1568026619666190122144217

[30]

Zhang Arch. Pharm. (2020) 10.1002/ardp.201900240

[31]

Zhang Chem. – Eur. J. (2015) 10.1002/chem.201502543

[32]

Tian Molecules (2016) 10.3390/molecules21060758

[33]

Yu Eur. J. Med. Chem. (2018) 10.1016/j.ejmech.2018.04.005

[34]

Bauer Nat. Protoc. (2023) 10.1038/s41596-023-00825-8

[35]

Makarem Synlett (2019) 10.1055/s-0039-1690194

[36]

Makarem J. Org. Chem. (2019) 10.1021/acs.joc.9b00832

[37]

Klika Dalton Trans. (2022) 10.1039/d2dt01702d

[38]

Yu Molecules (2019) 10.3390/molecules24091672

[39]

Rani Anti-Cancer Agents Med. Chem. (2021) 10.2174/1871520621666210112112422

[40]

Zhang Eur. J. Med. Chem. (2019) 10.1016/j.ejmech.2019.02.055

[41]

Gao Eur. J. Med. Chem. (2019) 10.1016/j.ejmech.2019.04.043

[42]

Fu Eur. J. Med. Chem. (2019) 10.1016/j.ejmech.2019.01.033

[43]

Kraljević Eur. J. Med. Chem. (2016) 10.1016/j.ejmech.2016.08.062

[44]

Bistrović New J. Chem. (2017) 10.1039/c7nj01469d

[45]

An Molecules (2018) 10.3390/molecules23092281

[46]

Dhawan Chem. Biodiversity (2020) 10.1002/cbdv.201900462

[47]

Ansary ChemistrySelect (2019) 10.1002/slct.201900114

[48]

Raj Tetrahedron Lett. (2017) 10.1016/j.tetlet.2017.04.052

[49]

Chekir Bioorg. Chem. (2018) 10.1016/j.bioorg.2018.06.005

[50]

Sinha Bioorg. Med. Chem. Lett. (2016) 10.1016/j.bmcl.2016.09.078

Showing 50 of 241 references

Cited By

96

Recent Advances in the Multicomponent Synthesis of Heterocycles using Thiosemicarbazide

Ramin Javahershenas, Mosstafa Kazemi · 2024

ChemistrySelect

Metrics

96

Citations

241

References

Details

Published: Jan 01, 2024
Vol/Issue: 15(1)
Pages: 10-54
License: View

Authors

M

Manankar Koley

CSIR-Central Glass & Ceramic Research Institute, Kolkata, India

J

Jingjing Han

College of Chemical Engineering, Nanjing Forestry University, Nanjing, China

V

Vadim A. Soloshonok

Department of Organic Chemistry I, University of the Basque Country, San Sebastián, Spain; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain

S

Subhajit Mojumder

CSIR-Central Glass & Ceramic Research Institute, Kolkata, India

R

Ramin Javahershenas

Department of Organic Chemistry, Faculty of Chemistry, Urmia University, Urmia, Iran

A

Ata Makarem

Institute of Pharmacy, University of Hamburg, Hamburg, Germany

Cite This Article

Manankar Koley, Jingjing Han, Vadim A. Soloshonok, et al. (2024). Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies. RSC Medicinal Chemistry, 15(1), 10-54. https://doi.org/10.1039/d3md00511a

Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies

You May Also Like